S&P 500

5.942,47

1,26%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GNMSF

Genmab A S (PK) (GNMSF)

Genmab A S (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:GNMSF

1 2 3 4 5 6 7 8 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
06/11/2024	17h11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
15/10/2024	16h34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
04/10/2024	21h16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
01/10/2024	16h33	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
26/09/2024	21h23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
08/08/2024	17h14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
08/08/2024	17h07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
20/06/2024	16h54	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
18/06/2024	21h46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
17/06/2024	16h01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
08/05/2024	18h46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
07/05/2024	20h46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
10/06/2020	13h34	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
04/06/2020	16h56	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
03/06/2020	22h48	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
28/05/2020	22h15	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
13/05/2020	20h48	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
12/05/2020	20h01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
06/05/2020	20h32	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
01/05/2020	21h03	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
30/04/2020	22h09	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
14/04/2020	15h48	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
01/04/2020	23h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
01/04/2020	16h30	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
31/03/2020	22h01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
31/03/2020	15h39	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
30/03/2020	23h16	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:GNMSF	Genmab A S (PK)
26/03/2020	22h13	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
26/03/2020	17h03	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
24/03/2020	17h59	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)